根据2011年卫生账户体系跟踪药品支出

Tracking pharmaceuticalexpenditure under the Systemof Health Accounts 2011 Tracking pharmaceutical expenditure under the System of Health Accounts 2011 ISBN 978-92-4-011725-9 (electronic version)ISBN 978-92-4-011726-6 (print version) © World Health Organization2025 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0IGO licence(CCBY-NC-SA3.0IGO;https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, providedthe workis appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specificorganization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license yourwork under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the followingdisclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is notresponsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition.” Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the WorldIntellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/). Suggested citation.Tracking pharmaceutical expenditure under the System of Health Accounts 2011. Geneva: World HealthOrganization; 2025. Licence:CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.CIP data are available athttps://iris.who.int/. Sales, rights and licensing.To purchase WHO publications, seehttps://www.who.int/publications/book-orders. To submit requestsfor commercial use and queries on rights and licensing, seehttps://www.who.int/copyright. Third-party materials.If you wish to reuse material from this work that is attributed to a third party, such as tables, figures orimages, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyrightholder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user. General disclaimers.The designations employed and the presentation of the material in this publication do not imply the expressionof any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities,or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border linesfor which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommendedby WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietaryproducts are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the publishedmaterial is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation anduse of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Contents 2.1Boundaries of pharmaceutical expenditure in SHA2011. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .32.2The pharmaceutical supply chain and distribution systems. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .42.3Determining the relevant price when measuring pharmaceutical expenditure. . . . . . . . . . . . . . . . . . . . . . . . .6 3. Measuring pharmaceutical expenditure under SHA 2011. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10 3.1Pharmaceutical expenditure in the health care function classification (ICHA-HC) of SHA 2011. . . . . . . . . . .103.2Pharmaceutical expenditure in the factors of health care provision classification (ICHA-FP) of SHA 2011.143.3Bringing it together. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .15 4. Data sources and methods for estimating pharmaceutical expenditures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17 4.1Routine reports. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .184.2Regular statistics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .274.3Irregular and ad hoc statistics for health accounts purposes. . . . . . . . . . . . . . . . .